&nbsp;

NSCLCTreatmentPathwayMap.pdf

Nov 2017

Document

NDFP & EBP Resubmissions and Appeals Policy

Dec 1969

Regimen

TMZL

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Palliative

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Document

trilliumTakeThePledgePromo.png

Dec 1969

Regimen

NELA

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Drugs Used:

nelarabine (Unfunded)

Quick Link(s):

Regimen Monograph

Blog posts

New cancer statistics: Better outcomes, but increasing need in Ontario

This year, more than 90,000 people in Ontario will discover they have cancer. Approximately one in two Ontarians are expected to be diagnosed with...

Jan 2018

Regimen

NIVL

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Drugs Used:

nivolumab (Unfunded)

Quick Link(s):

Regimen Monograph

Regimen

TRIFTIPI

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Drugs Used:

trifluridine / tipiracil (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2021

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab - Adjuvant Treatment for Completely Resected Stage IIB or IIC Melanoma

New Drug Funding Program

Nivolumab - Adjuvant Treatment for Completely Resected Stage III or IV Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Oct 2024

Regimen

TALI

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Drugs Used:

talimogene laherparepvec (Unfunded)

Quick Link(s):

Regimen Monograph

Document

Thyroid ASIR-F 1999-2003.jpg

Dec 1969

Document